Polymeric Matrices
Polymeric Matrices - Related Videos
06:45
Polymerization
0 Views •
2023
Source: Vy M. Dong and Jan Riedel, Department of Chemistry, University of California, Irvine, CA Polymers are made from macromolecules, which are composed of repeating units (the so called monomeric units). In our modern world, polymers play an important role. One of the first important polymers was nylon, which is a polyamide. It found widespread application in tooth brushes and stockings.
07:58
Invasion Assay Using 3D Matrices
0 Views •
2023
The extracellular matrix (ECM) is a network of molecules that provide a structural framework for cells and tissues and helps facilitate intercellular communication. Three-dimensional cell culture techniques have been developed to more accurately model this extracellular environment for in vitro study. While many cell processes during migration through 3D matrices are similar to those required for movement across rigid 2D surfaces, including adherence, migration through ECM also requires cells...
11:38
Preparation of Complaint Matrices for Quantifying Cellular Contraction
0 Views •
Cited by 115 •
2010
In this video, we demonstrate the experimental techniques used to fabricate compliant, extracellular matrix (ECM) coated substrates suitable for cell culture, and which are amenable to traction force microscopy and observing effects of ECM stiffness on cell behavior.
07:28
Ethylene Polymerizations Using Parallel Pressure Reactors and a Kinetic Analysis of Chain Transfer Polymerization
0 Views •
2015
A protocol for the high-throughput analysis of polymerization catalyst, chain transfer polymerizations, polyethylene characterization, and reaction kinetic analysis is presented.
10:01
Kinetics of Addition Polymerization to Polydimethylsiloxane
0 Views •
2023
Source: Kerry M. Dooley and Michael G. Benton, Department of Chemical Engineering, Louisiana State University, Baton Rouge, LA Polymers are molecules consisting of many repeating monomer units that are chemically bonded into long chains. They exhibit a broad range of physical properties, which are affected by their chemical structure, molecular weight and degree of polymerization. The polymer industry manufactures thousands of raw materials used in a broad variety of commercial products.1,2 The...
FAQs
Polymer composition, chain interactions, and crosslinking jointly determine how a matrix behaves under clinical use. Stronger interactions or more extensive crosslinking can alter mechanical strength and swelling, while composition influences degradation and compatibility. Researchers therefore adjust these variables to obtain a structure that remains sufficiently supportive while still permitting the intended transport or therapeutic function.
Porosity and swelling regulate the pathways available for molecules moving through the matrix. Porous structures can provide space for transport, while swelling changes the hydrated network through which compounds diffuse. Because diffusion affects how incorporated compounds move outward, these features help determine whether treatment remains localized and how consistently it is released over time.
Degradation creates a changing matrix rather than a permanently fixed one. As the material breaks down, its mechanical support, transport behavior, and release characteristics may also change. A faster or slower degradation profile can therefore influence whether a matrix provides temporary structural assistance, maintains localized therapy, or loses its intended function before the clinical need is addressed.
Researchers tailor the matrix by modifying polymer composition, chain interactions, crosslinking, porosity, swelling, and degradation. These adjustments allow them to balance biocompatibility, mechanical strength, molecular diffusion, and therapeutic release rather than optimizing only one property. The selected combination depends on whether the intended role is localized drug delivery, temporary tissue support, or wound management.
In clinical research, polymeric matrices are investigated for drug-delivery systems, tissue-engineering scaffolds, and wound-management materials. Drug-delivery designs can localize treatment and regulate release, whereas tissue-engineering applications emphasize temporary structural support. Wound-management uses likewise draw on localized therapeutic function and material support, with matrix properties adjusted to the requirements of each setting.
Evaluation focuses on whether the material combines biocompatibility with an appropriate degradation rate and therapeutic release profile. Researchers also consider mechanical strength, swelling, diffusion, and the ability to localize treatment or provide temporary support. Together, these outcomes show whether the matrix properties match the intended clinical function rather than merely confirming that a scaffold or delivery system can be formed.